MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.76
+0.88 (8.09%)
Apr 29, 2026, 3:35 PM EDT - Market open
MiNK Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 13.36 | 4.58 | 3.37 | 19.64 | 38.89 | Upgrade
|
| Cash & Short-Term Investments | 13.36 | 4.58 | 3.37 | 19.64 | 38.89 | Upgrade
|
| Cash Growth | 191.90% | 35.93% | -82.85% | -49.51% | 1345.06% | Upgrade
|
| Prepaid Expenses | 0.28 | 0.25 | 0.05 | 0.3 | 0 | Upgrade
|
| Other Current Assets | 0.21 | 0.16 | 0.18 | 0.47 | 0.74 | Upgrade
|
| Total Current Assets | 13.85 | 4.99 | 3.6 | 20.4 | 39.63 | Upgrade
|
| Property, Plant & Equipment | 0.39 | 0.73 | 0.95 | 1.07 | 0.61 | Upgrade
|
| Total Assets | 14.24 | 5.72 | 4.55 | 21.47 | 40.24 | Upgrade
|
| Accounts Payable | 3.43 | 2.73 | 3.91 | 5.82 | 3 | Upgrade
|
| Accrued Expenses | 1.58 | 1.87 | 5.04 | 4.24 | 1.76 | Upgrade
|
| Current Portion of Long-Term Debt | 5.18 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 2.85 | 2.36 | 2.45 | 2.62 | 11.71 | Upgrade
|
| Total Current Liabilities | 13.03 | 6.96 | 11.4 | 12.68 | 16.47 | Upgrade
|
| Long-Term Debt | - | 4.92 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 15.44 | 13.42 | 11.21 | 9.19 | - | Upgrade
|
| Total Liabilities | 28.47 | 25.31 | 22.61 | 21.87 | 16.47 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 143.17 | 125.23 | 115.77 | 110.83 | 107.35 | Upgrade
|
| Retained Earnings | -156.68 | -144.18 | -133.4 | -110.94 | -82.95 | Upgrade
|
| Comprehensive Income & Other | -0.72 | -0.63 | -0.43 | -0.29 | -0.63 | Upgrade
|
| Shareholders' Equity | -14.23 | -19.59 | -18.06 | -0.4 | 23.78 | Upgrade
|
| Total Liabilities & Equity | 14.24 | 5.72 | 4.55 | 21.47 | 40.24 | Upgrade
|
| Total Debt | 5.18 | 4.92 | - | - | - | Upgrade
|
| Net Cash (Debt) | 8.18 | -0.35 | 3.37 | 19.64 | 38.89 | Upgrade
|
| Net Cash Growth | - | - | -82.85% | -49.51% | - | Upgrade
|
| Net Cash Per Share | 1.92 | -0.09 | 0.98 | 5.83 | 14.94 | Upgrade
|
| Filing Date Shares Outstanding | 4.97 | 3.97 | 3.47 | 3.39 | 3.36 | Upgrade
|
| Total Common Shares Outstanding | 4.71 | 3.96 | 3.46 | 3.39 | 3.35 | Upgrade
|
| Working Capital | 0.82 | -1.97 | -7.8 | 7.72 | 23.17 | Upgrade
|
| Book Value Per Share | -3.02 | -4.94 | -5.22 | -0.12 | 7.10 | Upgrade
|
| Tangible Book Value | -14.23 | -19.59 | -18.06 | -0.4 | 23.78 | Upgrade
|
| Tangible Book Value Per Share | -3.02 | -4.94 | -5.22 | -0.12 | 7.10 | Upgrade
|
| Machinery | 1 | 1.26 | 1.45 | 1.35 | 0.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.